Skip to content
Use caution Drug recall · FDA · Published December 22, 2014

Qualitest Recalls Acetaminophen/Codeine Oral Solution Due to Impurities

Qualitest Pharmaceuticals recalls specific lots of Acetaminophen and Codeine Oral Solution due to high levels of the impurity p-Aminophenol.

🇺🇸 FDA recall #D-0331-2015DrugQualitest Pharmaceuticals ›
Take action

Contact the company

Recalling firmQualitest Pharmaceuticals120 Vintage Dr NE · Huntsville, AL 35811-8216
✎ GovInfoNow plain-language explainer

What happened, in plain English

Qualitest Pharmaceuticals is recalling Acetaminophen and Codeine Phosphate Oral Solution USP because it contains high levels of an out-of-specification impurity called p-Aminophenol. The recall affects specific lots of both 4 oz. and one-pint bottles distributed nationwide. The record does not specify the current remedy or return instructions for consumers. Read more at govinfonow.com/recall/45074-qualitest-pharmaceuticals-recalls-acetaminophen-and-codeine-phosphate-oral-solution-usp.

Source Summary by GovInfoNow · govinfonow.com/recall/45074-qualitest-pharmaceuticals-recalls-acetaminophen-and-codeine-phosphate-oral-solution-usp · Updated October 12, 2026 · FDA enforcement record: FDA #D-0331-2015

Cite this page

“Qualitest Recalls Acetaminophen/Codeine Oral Solution Due to Impurities.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45074-qualitest-pharmaceuticals-recalls-acetaminophen-and-codeine-phosphate-oral-solution-usp. Based on FDA recall #D-0331-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0331-2015%22&limit=1).

Why it’s dangerous

The product failed impurity specifications due to high results for p-Aminophenol, a known degradation product. While the record identifies this as a Class III recall (typically associated with products unlikely to cause adverse health consequences), the presence of excessive impurities means the medication does not meet quality standards.

Who’s affected

Patients who have been prescribed this specific oral solution by a healthcare provider are affected. Individuals possessing the listed lot numbers from Qualitest Pharmaceuticals are at risk of consuming medication that does not meet purity standards.

How to tell if you have this one

Check if you have Acetaminophen and Codeine Phosphate Oral Solution USP, 120 mg/12 mg per 5 mL, manufactured by Qualitest Pharmaceuticals. Look for NDC 0603-9013-54 (4 oz. bottles) or NDC 0603-9013-58 (one-pint bottles). Verify the lot number against the recall list: L140H13B, L001D14A, L140H13A, L205K13A, L019L13A, L020L13A, L001D14B, or L091D14A.

  • Brand
    Qualitest Pharmaceuticals
  • Product
    ACETAMINOPHEN and CODEINE PHOSPHATE ORAL SOLUTION USP, 120 mg/12 mg per 5 mL, packaged in a) 4 oz. (120 mL) bottles
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Lot Number

    Compare the lot number on your bottle against the recalled lots listed in the record to see if your specific product is included.

  2. Contact Your Pharmacist

    Reach out to the pharmacy where you filled the prescription for guidance on how to proceed with the recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Dec 22, 201412. FDA classified it Class III: Jan 6, 201523. Published in FDA’s Enforcement Report: Jan 14, 201534. FDA terminated the recall: Feb 1, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0331-2015 (December 22, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0331-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA